Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Clinical Trial Imaging Market, by Region, 2020-2030 (USD Billion)
1.2.2. Clinical Trial Imaging Market, by Product and Service, 2020-2030 (USD Billion)
1.2.3. Clinical Trial Imaging Market, by Modality, 2020-2030 (USD Billion)
1.2.4. Clinical Trial Imaging Market, by End-User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Clinical Trial Imaging Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Clinical Trial Imaging Market Dynamics
3.1. Clinical Trial Imaging Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing number of clinical trials
3.1.1.2. Growing number of Contract Research Organizations (CROs)
3.1.2. Market Challenges
3.1.2.1. High-Risk Radiation Causing Diseases
3.1.2.2. Stringent Regulatory Policies
3.1.3. Market Opportunities
3.1.3.1. Surge in R&D expenditure in pharmaceutical and biotechnological companies
3.1.3.2. Rise in Healthcare Expenditure across the world
Chapter 4. Global Clinical Trial Imaging Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Clinical Trial Imaging Market, by Product and Service
5.1. Market Snapshot
5.2. Global Clinical Trial Imaging Market by Product and Service, Performance - Potential Analysis
5.3. Global Clinical Trial Imaging Market Estimates & Forecasts by Product and Service 2020-2030 (USD Billion)
5.4. Clinical Trial Imaging Market, Sub Segment Analysis
5.4.1. Trial Design Consulting Services
5.4.2. Read Analysis Services
5.4.3. Operational Imaging Services
5.4.4. Imaging Software
Chapter 6. Global Clinical Trial Imaging Market, by Modality
6.1. Market Snapshot
6.2. Global Clinical Trial Imaging Market by Modality, Performance - Potential Analysis
6.3. Global Clinical Trial Imaging Market Estimates & Forecasts by Modality 2020-2030 (USD Billion)
6.4. Clinical Trial Imaging Market, Sub Segment Analysis
6.4.1. Magnetic Resonance Imaging
6.4.2. Computed Tomography
6.4.3. Ultrasound
6.4.4. Positron Emission Tomography
6.4.5. X-Ray
6.4.6. Echocardiography
6.4.7. Other Modalities
Chapter 7. Global Clinical Trial Imaging Market, by End-User
7.1. Market Snapshot
7.2. Global Clinical Trial Imaging Market by End-User, Performance - Potential Analysis
7.3. Global Clinical Trial Imaging Market Estimates & Forecasts by End-User 2020-2030 (USD Billion)
7.4. Clinical Trial Imaging Market, Sub Segment Analysis
7.4.1. Pharmaceutical & Biotechnology Companies
7.4.2. Medical Device Manufacturers
7.4.3. Academic and Government Research Institutes
Chapter 8. Global Clinical Trial Imaging Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Clinical Trial Imaging Market, Regional Market Snapshot
8.4. North America Clinical Trial Imaging Market
8.4.1. U.S. Clinical Trial Imaging Market
8.4.1.1. Product and Service breakdown estimates & forecasts, 2020-2030
8.4.1.2. Modality breakdown estimates & forecasts, 2020-2030
8.4.1.3. End-User breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Clinical Trial Imaging Market
8.5. Europe Clinical Trial Imaging Market Snapshot
8.5.1. U.K. Clinical Trial Imaging Market
8.5.2. Germany Clinical Trial Imaging Market
8.5.3. France Clinical Trial Imaging Market
8.5.4. Spain Clinical Trial Imaging Market
8.5.5. Italy Clinical Trial Imaging Market
8.5.6. Rest of Europe Clinical Trial Imaging Market
8.6. Asia-Pacific Clinical Trial Imaging Market Snapshot
8.6.1. China Clinical Trial Imaging Market
8.6.2. India Clinical Trial Imaging Market
8.6.3. Japan Clinical Trial Imaging Market
8.6.4. Australia Clinical Trial Imaging Market
8.6.5. South Korea Clinical Trial Imaging Market
8.6.6. Rest of Asia Pacific Clinical Trial Imaging Market
8.7. Latin America Clinical Trial Imaging Market Snapshot
8.7.1. Brazil Clinical Trial Imaging Market
8.7.2. Mexico Clinical Trial Imaging Market
8.8. Middle East & Africa Clinical Trial Imaging Market
8.8.1. Saudi Arabia Clinical Trial Imaging Market
8.8.2. South Africa Clinical Trial Imaging Market
8.8.3. Rest of Middle East & Africa Clinical Trial Imaging Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. IXICO plc
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Navitas Life Sciences
9.3.3. Resonance Health Ltd
9.3.4. ProScan Imaging
9.3.5. Radiant Sage LLC
9.3.6. Medpace Holdings, Inc
9.3.7. Biomedical Systems Corp
9.3.8. Cardiovascular Imaging Technologies
9.3.9. Intrinsic Imaging LLC
9.3.10. BioTelemetry, Inc
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption